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Abstract
Background  and  objectives:  It  is  crucial  to  decrease  bleeding  during  functional  endoscopic  sinus
surgery. Our  primary  goal  was  to  investigate  the  effects  of  magnesium  sulfate  and  dexmedeto-
midine  used  for  controlled  hypotension  on  the  visibility  of  the  surgical  site.
Methods: 60  patients  aged  between  18  and  65  years  were  enrolled.  In  the  magnesium  sulfate
group (Group  M),  patients  were  administered  40  mg/kg  magnesium  sulfate  in  100  mL  saline
solution  over  10  min  as  the  intravenous  loading  dose  10  min  before  induction,  with  a  subsequent
10--15  g/kg/h  infusion  during  surgery.  In  the  dexmedetomidine  group  (Group  D),  patients  were
administered  1  g/kg  dexmedetomidine  in  100  mL  saline  solution  as  the  loading  dose  10  min
before  surgery  and  0.5--1  g/kg/h  dexmedetomidine  during  surgery.  Deliberate  hypotension
was  deﬁned  as  a  mean  arterial  pressure  of  60--70  mmHg.
Results: Bleeding  score  was  signiﬁcantly  decreased  in  Group  D  (p  =  0.002).  Mean  arterial  pres-
sure  values  were  signiﬁcantly  decreased  in  Group  D  compared  to  that  in  Group  M,  except  for  the
initial  stage,  after  induction  and  5  min  after  intubation  (p  <  0.05).  The  number  of  patients  who
required  nitroglycerine  was  signiﬁcantly  lower  in  Group  D  (p  =  0.01)  and  surgeon  satisfaction  was
signiﬁcantly  increased  in  the  same  group  (p  =  0.001).  Aldrete  recovery  score  ≥9  duration  was
signiﬁcantly  shorter  in  Group  D  (p  =  0.001).  There  was  no  difference  between  the  two  groups  in
terms  of  recovery  room  verbal  numerical  rating  scale.
Conclusions:  Dexmedetomidine  can  provide  more  effective  controlled  hypotension  and  thus
contribute to  improved  visibility  of  the  surgical  site.
©  2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Comparac¸ão  entre  dexmedetomidina  e sulfato  de  magnésio  em  hipotensão
controlada  durante  cirurgia  funcional  endoscópica  dos  seios  paranasais
Resumo
Justiﬁcativa  e  objetivos:  Diminuir  o  sangramento  durante  a  cirurgia  funcional  endoscópica  dos
seios paranasais  é  essencial.  Nosso  objetivo  primário  foi  investigar  os  efeitos  de  dexmedeto-
midina  e  sulfato  de  magnésio,  usados  para  o  controle  da  hipotensão,  sobre  a  visibilidade  do
sítio  cirúrgico.
Métodos:  Foram  incluídos  no  estudo  60  pacientes  entre  18  e  65  anos.  No  grupo  sulfato  de
magnésio (Grupo  M),  receberam  40  mg  de  sulfato  de  magnésio  em  100  mL  kg−1 de  soluc¸ão  salina
durante  10  minutos  como  dose  de  carga  intravenosa  10  minutos  antes  da  induc¸ão  e  infusão
subsequente  de  10-15  g  kg−1 h−1 durante  a  cirurgia.  No  grupo  dexmedetomidina  (Grupo  D),
receberam  1  g  kg−1 de  dexmedetomidina  em  100  mL  de  soluc¸ão  salina  durante  10  minutos  como
dose  de  carga  10  minutos  antes  da  cirurgia  e  0,5-1  g  kg−1 h−1 de  dexmedetomidina  durante  a
cirurgia.  Hipotensão  controlada  foi  deﬁnida  como  pressão  arterial  média  de  60-70  mmHg.
Resultados: O  volume  de  sangramento  diminuiu  signiﬁcativamente  no  grupo  D  (p  =  0,002).  Os
valores da  pressão  arterial  média  foram  signiﬁcativamente  menores  no  Grupo  D,  em  comparac¸ão
com o  Grupo  M,  exceto  no  estágio  inicial,  pós-induc¸ão  e  cinco  minutos  pós-intubac¸ão  (p  <  0,05).
No  Grupo  D,  o  número  de  pacientes  que  necessitou  de  nitroglicerina  foi  signiﬁcativamente
menor (p  =  0,01)  e  o  grau  de  satisfac¸ão  do  cirurgião  foi  signiﬁcativamente  maior  (p  =  0,001).  O
tempo  de  recuperac¸ão  para  atingir  o  escore  de  Aldrete  ≥  9  foi  signiﬁcativamente  menor  no
grupo  D  (p  =  0,001).  Não  houve  diferenc¸a entre  os  dois  grupos  em  relac¸ão  aos  escores  da  escala
numérica  de  classiﬁcac¸ão  verbal  na  sala  de  recuperac¸ão.
Conclusões:  Dexmedetomidina  pode  proporcionar  um  controle  mais  eﬁcaz  da  hipotensão  e
contribuir,  assim,  para  uma  melhor  visibilidade  do  sítio  cirúrgico.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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ontrolled  hypotension  is  performed  in  order  to  reduce
lood loss  and  the  need  for  transfusion  during  the  surgery
nd to  improve  visibility  of  the  surgical  site  by  decreasing
he arterial  pressure  until  hypotension  is  reached.1 The
rimary surgical  treatment  for  chronic  rhinosinusitis  is
unctional endoscopic  sinus  surgery  (FESS).  Intraoperative
leeding can  diminish  the  visibility  of  the  surgical  site,
eading to  an  increased  rate  of  complications.  Therefore,
mproving the  visibility  of  the  surgical  site  by  reducing  bleed-
ng during  FESS  is  an  important  issue  for  anesthesiologists.2
n  controlled  hypotension,  several  agents  have  been  used,
ither alone  or  in  combination  with  each  other;  however,  an
deal agent  for  inducing  controlled  hypotension  cannot  be
sserted. The  ideal  agent  used  for  controlled  hypotension
ust have  certain  characteristics,  such  as  ease  of  adminis-
ration, a  short  onset  time,  an  effect  that  disappears  quickly
hen administration  is  discontinued,  rapid  elimination  with-
ut toxic  metabolites,  negligible  effects  on  vital  organs,  and
redictable and  dose-dependent  effects.1,3--5
Dexmedetomidine  is  a  highly  selective  2-adrenoceptor
gonist with  sedative,  anxiolytic,  and  analgesic  char-
cteristics. Dexmedetomidine  mediates  central  2A and
midazoline type  1  receptors.  The  activation  of  these  cen-
ral receptors  results  in  a  decrease  in  norepinephrine  release
nd leads  to  a  decrease  in  blood  pressure  and  heart  rate.6
T
dIt  has  been  reported  that  magnesium  sulfate  is  a  good
gent for  controlled  hypotension,  and  that  it  stabilizes  the
ell membrane  and  intracytoplasmic  organelles  by  medi-
ting the  activation  of  Na+-K+ ATPase  and  Ca++ ATPase
nzymes, which  play  a  role  in  transmembrane  ion  exchange
uring the  depolarization  and  repolarization  phases.5,7,8 In
ddition, Mg++ inhibits  the  release  of  norepinephrine  by
locking the  N-type  Ca++ channels  at  nerve  endings  and  thus
ecrease the  blood  pressure.9
There  are  several  studies  which  have  assessed  the  effec-
iveness of  dexmedetomidine  and  magnesium  sulfate  in
ontrolled hypotension.  These  two  agents  have  been  com-
ared with  other  hypotensive  agents  in  terms  of  their  role  in
ypotensive anesthesia,  but  to  the  best  of  our  knowledge,
o study  comparing  these  two  agents  with  each  other  has
een cited  in  the  scientiﬁc  literature.2,5,7,10
Our  primary  goal  in  this  study  was  to  compare  the  effects
f dexmedetomidine  and  magnesium  sulfate  agents  on  the
isibility of  the  surgical  site;  our  secondary  goal  was  to  com-
are these  two  agents  in  terms  of  satisfaction  of  the  surgeon,
ecovery period,  adverse  effects  and  postoperative  analge-
ia.
aterials and methodshis  study  is  a randomized,  prospective  study  and  was  con-
ucted on  60  ASA  I--II  patients  aged  between  18  and  65  years
e
p
o
n
1
u
0
b
w
5
t
p
m
U
a
t
w
f
3
F
u
S
t
m
a
t
n
i
L
T
n
d
i
T
a
a
v
s
t
t
t
p
w
e
p
A
w
r
t
i
b
a
t
r
s
sControlled  hypotension  
who  were  selected  for  FESS,  between  January  2012  and  July
2013. This  study  was  approved  by  the  local  ethics  committee
(No: 2011-221),  and  informed  consent  was  obtained  from
the patients.  The  study  was  conducted  according  to  the
Declaration of  Helsinki.  Patients  with  kidney,  liver,  hemato-
logical and  neuromuscular  diseases,  diabetic  neuropathy  or
any known  allergy  history  to  studied  agents  were  excluded
from the  study.  Those  with  a  body  weight  exceeding  the  ideal
body weight  by  more  than  30%  and  those  receiving  calcium
channel blockers,  non-steroidal  anti-inﬂammatory  drugs,
agents affecting  neuromuscular  blockage,  and  agents  con-
traindicated for  controlled  hypotension  were  also  excluded
from the  study.  Patients  and  their  relatives  were  informed
for verbal  numerical  rating  scale  (NRS)  (0:  no  pain,  10:
severe pain)  at  the  preoperative  patient  examination.
All patients  were  administered  a  5  mL/kg/hour  intra-
venous (i.v.)  isotonic  solution(Lactated  Ringer)  infusion  2  h
before the  induction,  which  was  continued  during  the
surgery.
After the  patients  were  taken  into  the  operating  room,
mean arterial  pressure  (MAP),  heart  rate  (HR),  peripheral
oxygen saturation  (SpO2)  and  end  tidal  carbon  dioxide  were
monitored (Datex  Ohmeda  S/5,  Helsinki,  Finland);  hemody-
namic data  were  measured  every  5  min.  Hemodynamic  data
were recorded  at  the  initial  phase,  after  the  induction,  5,
10, 15,  30  and  45  min  after  intubation,  and  1  and  5  min  after
extubation.
Patients were  divided  into  two  groups  by  choosing
randomly from  sealed  envelopes.  The  study  participants,
operation nurse  and  the  otorhinolaryngologist  constituted
the ‘blind’  study  group.  An  anesthetist  who  did  not  take
part in  the  intra-operative  follow-up  prepared  the  medicine
used. For  topical  vasoconstriction  and  local  anesthesia,
1/1000 epinephrine  soaked  cotton  was  placed  in  the
nasal cavity  for  5  min.  A  solution  containing  40  mg/2  mL
lidocaine hydrochloride  +  0.025  mg/2  mL  epinephrine  (Jeto-
caine, Adeka,  Istanbul,  Turkey)  was  applied  to  the  nasal  side
of both  the  medial  and  lateral  conchae  at  the  same  dose.
To the  patients  in  Group  M,  40  mg/kg  i.v.  magnesium  sul-
fate (OSEL, I˙stanbul,  Turkey)  in  100  mL  saline  solution  was
applied as  a  loading  dose  10  min  before  the  induction  and
then titrated  at  an  infusion  rate  of  10--15  mg/kg/hour  to
maintain MAP  within  the  target  range  during  surgery.  To
the patients  in  group  D,  1  g/kg  i.v.  dexmedetomidine  (Pre-
cedex; Hospira,  Rocky  Mount,  NC,  USA)  in  100  mL  saline
solution was  applied  10  min  before  surgery  and  then  titrated
at an  infusion  rate  of  0.5--1  g/kg/hour  to  maintain  MAP
with in  the  target  range  during  surgery.  These  dosages  were
based on  a  previous  study,5,10--12 whereas  the  magnesium
and dexmedetomidine  infusion  rates  were  chosen  to  sus-
tain the  target  MAP  and  avoid  the  serious  hemodynamic  side
effects.
Deliberate hypotension  was  deﬁned  as  an  MAP  of
60--70 mmHg7;  50  g  nitroglycerine  was  applied  in  the  pres-
ence of  MAP  exceeding  70  mmHg  and  5  mg  ephedrine  was
applied in  the  presence  of  MAP  under  55  mmHg.  Bradycar-
dia was  deﬁned  as  a  heart  rate  decreased  by  more  than  20%
of the  initial  heart  rate;  0.5  mg  i.v.  atropine  was  applied  to
patients who  developed  bradycardia.
Neuromuscular  stimulus  was  monitored  via  accelome-
try of  the  right  adductor  pollicis  muscle  in  all  patients
(TOF-Guard®;  Biometer,  Denmark).  After  placing  the  surface
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lectrodes  on  the  ulnar  nerve  area  of  the  wrist,  2.5  mg/kg
ropofol and  1  g/kg  fentanyl  i.v.  were  administered  in
rder to  induce  anesthesia.  After  achieving  unconscious-
ess, single  muscle  twitch  auto-calibration  at  the  level  of
00% was  performed  with  the  use  of  supramaximal  stim-
lus (60  mA)  before  rocuronium  injection.  To  the  patient
.6 mg/kg  i.v.  rocuronium  was  injected  and  orotracheal  intu-
ation was  performed  after  achieving  T1  =  0%.  Anesthesia
as maintained  with  50%  nitrous  oxide  and  50%  oxygen,  and
--6% desﬂurane  was  adjusted  to  achieve  a  target  Bispec-
ral Index  (BIS)  between  40  and  60.  The  BIS  electrodes  were
laced on  the  forehead  and  were  connected  to  an  A-2000  BIS
onitoring system  (Aspect  Medical  System  Inc.  Natick,  MA,
SA). The  presence  of  hypertension  or  tachycardia  during
nesthesia, while  BIS  was  between  40  and  60,  was  attributed
o insufﬁcient  analgesia  and  a  bolus  dose  of  fentanyl  1  g/kg
as given.
Volume-controlled mechanical  ventilation  was  per-
ormed with  an  end-tidal  carbon  dioxide  pressure  between
5 and  40  mmHg  (Avance  S/5,  GE  Datex-Ohmeda,  Helsinki,
inland). Patients  were  intraoperatively  warmed  with  an
nderbody heated  blanket  (Astoped  Duo  120  control  unit,
tuttgart, Baden-Wurttemberg,  Germany).  Skin  tempera-
ure of  the  patient  measured  on  the  adductor  pollicis
uscle was  maintained  above  32 ◦C.  An  esophageal  temper-
ture probe  was  inserted  into  the  lower  esophagus  after
he intubation  for  measuring  the  core  temperature,  and
ormothermia was  accomplished  with  the  use  of  warmed
ntravenous ﬂuids  (enFlow  IV  Fluid/Blood  warmer  system,
exington, MA,  USA)  during  the  surgery.  In  the  presence  of
1 exceeding  25%  of  the  control  value,  0.15  mg/kg  rocuro-
ium was  applied  in  order  to  maintain  the  T1  under  10%
uring surgery.  Magnesium  sulfate  and  dexmedetomidine
nfusions were  discontinued  at  the  end  of  the  surgery.
hen, 0.02  mg/kg  atropine  and  0.04  mg/kg  neostigmine  was
pplied in  order  to  antagonize  the  neuromuscular  block-
ge in  the  presence  of  T1  responses  exceeding  the  control
alue by  25%.  The  periods  between  stopping  the  anesthe-
ia and  extubation  and  between  extubation  and  opening
he eyes  with  a  loud  verbal  stimulus  were  determined  as
he extubation  duration  and  eye  opening  duration,  respec-
ively. Patients  were  extubated  when  BIS  ≥  70.  The  time
assing until  an  Aldrete  post-anesthesia  recovery  score  ≥9
as  deﬁned  as  the  recovery  period.13 Aldrete  score  was
valuated by  an  anesthetist  who  was  ‘blind’  in  terms  of
atient groups  every  15  min  for  60  min.  Patients  with  an
ldrete score  ≥9  were  transferred  to  the  ward.  All  patients
ere operated  by  the  same  surgeon,  and  surgical  site  was
ated according  to  a 6-point  scale  every  5  min  by  him  in
erms of  bleeding  and  dryness  (Table  1)14: 0  =  no  bleed-
ng; 1  =  minor  bleeding,  no  aspiration  required;  2  =  minor
leeding, aspiration  required;  3  =  minor  bleeding,  frequent
spiration required;  4  =  moderate  bleeding,  visible  only  with
he aspiration;  and  5  =  severe  bleeding,  continuous  aspi-
ation required,  very  hard  to  perform  surgery.  Surgeon
atisfaction was  scored  by  the  same  surgeon  with  a  4-point
cale: 1  =  bad,  2  =  moderate,  3  =  good,  4  =  excellent.
All intraoperative  and  postoperative  complications  were
ecorded. Patients  with  NRS  >  4  were  treated  with  50  mg
exketoprofen i.v.,  and  those  with  nausea  were  given  10  mg
etoclopramide i.v.  Patients  who  displayed  shivering  were
armed with  heated  blankets.
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Table  1  Category  scale  for  assessment  of  intraoperative  surgical  ﬁeld  and  surgeon  satisfaction  score.
Variable  Group  D
(n =  30)  (%)
Group  M
(n =  30)  (%)
p-Value
Bleeding  score  (n;  %)  0.002
0  2  (6.6)  0  (0)
1  21  (70)  10  (33.3)
2  6  (20)  11  (36.6)
3  1  (3.3)  5  (16.6)
4  0  (0)  4  (13.3)
5  0  (0)  0  (0)
Satisfaction  score  (n;%) 0.001
1  0  (0) 4 (13.3)
2  2  (6.6) 10 (33.3)
3  8  (26.6)  8  (26.6)
4  20  (66.6)  8  (26.6)
Group D, dexmedetomidine group; Group M, magnesium sulfate group
Data show the number of cases and the percentage rate. p value calculated using Chi-square test.
Bleeding score: 0 = no bleeding; 1 = slight bleeding-no suction of blood required; 2 = slight bleeding-occasional suctioning required. Sur-
gical ﬁeld not threatened; 3 = slight bleeding-frequent suctioning required. Bleeding threatens surgical ﬁeld a few seconds after suction
is removed; 4 = moderate bleeding-frequent suctioning required. Bleeding threatens surgical ﬁeld directly after suction is removed;
5 = severe bleeding-constant suctioning required. Bleeding appears faster than can be removed by suction. Surgical ﬁeld severely threat-
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aened and surgery not possible.
Satisfaction  score: 1 = poor; 2 = moderate; 3 = good; 4 = very good.
tatistical  analysis  and  study  sample  size
alculation
ll  statistical  analyses  were  performed  R  3.0.2  software
www.r-project.org). Student’s  t test  was  used  for  the
omparison  of  hemodynamic  parameters  and  duration  of
nesthesia, operation,  extubation,  eye  opening,  and  Aldrete
ecovery score  ≥9.  Mann--Whitney  U  test  was  used  for  the
omparison of  NRS  values;  Chi-square  test  was  used  to  com-
are surgeon  satisfaction  and  visibility  of  the  surgical  site,
hile Fisher’s  exact  test  was  used  in  comparison  of  brady-
ardia, hypotension,  vomiting,  shivering,  and  number  of
atients requiring  fentanyl  and  nitroglycerine  administra-
ion. To  determine  the  changes  over  time  in  each  group,
e used  repeated  measures  ANOVA,  and  multiple  compar-
sons were  corrected  using  Bonferroni’s  method.  p  <  0.05  was
eﬁned as  statistically  signiﬁcant.  Sample  size  calculation
as based  on  the  initial  pilot  study.  Since  ,   and  average
ifference values  were  calculated  as  0.05,  0.20  and  0.5,
espectively, (1.1  ±  0.56  and  1.6  ±  0.69)  for  10  patients  in
ach group  in  terms  of  the  20th  min  bleeding  score,  a  min-
mum of  25  patients  were  calculated  as  necessary  for  each
roup.
esults
ixty  patients  were  enrolled  in  the  study  and  all  patients
ompleted the  study.  Demographic  data,  BIS  values,  total
ocuronium necessity,  duration  of  operation  and  anesthe-
ia were  similar  in  each  group  (p  >  0.05)  (Table  2).  MAP
as signiﬁcantly  lower  in  Group  D  than  in  Group  M  for  all
easurements except  the  initial  stage,  after  induction  and
 min  after  intubation  (p  <  0.05)  (Fig.  1).  HR  was  signiﬁcantly
ower in  all  measurements  except  the  initial  stage  in  Group
h
o
s
s compared  to  Group  M  (p  <  0.05)  (Fig.  2).  Bleeding  score
as signiﬁcantly  decreased  in  group  D  (p  =  0.002)  (Table  1,
ig. 3).  Surgeon  satisfaction  was  signiﬁcantly  better  in  Group
 (p:  0.001)  (Table  1).
There  was  no  signiﬁcant  difference  between  the  two
roups in  terms  of  bradycardia,  hypotension,  vomiting,  shiv-
ring and  fentanyl  necessity.  Nitroglycerine  necessity  was
igniﬁcantly lower  in  Group  D  (p  =  0.01)  (Table  2).  The  two
roups were  similar  in  terms  of  extubation  and  eye  open-
ng duration.  The  duration  until  reaching  an  Aldrete  score
9 was  signiﬁcantly  shorter  in  Group  D  (p  =  0.001)  (Table  2).
here was  no  difference  in  terms  of  the  15th,  30th,  45th
nd 60th  min  NRS  scores  [Group  D  =  3  (2--6);  3  (2--6);  3(2--5);
 (2--4);  Group  M  =  3  (1--6);  3  (1--6);  3  (2--5);  3  (2--5)  median
min--max) respectively]  (p  >  0.05).
iscussion
his  study  revealed  that  dexmedetomidine  was  more  effec-
ive in  performing  controlled  hypotension  during  FESS  and
hat it  provided  a better  surgical  site  and  surgeon  satisfac-
ion and  a  lower  necessity  of  additional  hypotensive  agent
han magnesium  sulfate.
In  a  study  assessing  the  hypotensive  effects  of
exmedetomidine  administered  as  a  0.4  g/kg/hour  i.v.
nfusion following  a  1  g/kg  i.v.  bolus  dose  in  middle  ear
urgery, it  has  been  reported  that  surgeon  satisfaction  was
ncreased and  inhalation  agent  necessity  to  decrease  the
AP by  up  to  30%  was  decreased  in  the  dexmedetomidine
dministered  patient  group.15 Secondary  decrease  in  the
eart rate  and  blood  pressure  due  to  the  inhibiting  effects
f dexmedetomidine  on  central  sympathetic  stimulus  and
timulation of  the  peripheral  ˛2 adrenoceptors  in  vascular
mooth muscle  tissue  is  considered  to  be  responsible  for
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Table  2  Perioperative  characteristics  and  data.
Group  D  (n  =  30)  Group  M  (n  =  30)  p-Value
Gender  (F/M)  22/8  19/11  0.54a
Age  (year)  45.1  ±  11.1  39.5  ±  11.3  0.77
Body  weight  (kg)  76.6  ±  6.1  76.7  ±  12.5  0.95
Duration  of  anesthesia  (min)  67.4  ±  20.5  72  ±  17.3  0.39
Duration  of  surgery  (min)  55.9  ±  18.3  61.5  ±  17.3  0.26
Extubation  time  (min)  4.5  ±  2.3  5.8  ±  2.9  0.08
Eye  opening  time  (min)  4.1  ±  1.9  4.6  ±  2.2  0.39
Time  required  to  reach  Aldrete  score  ≥9  (min) 11.8 ±  2.5  14.8  ±  3.0  0.001
Bradycardia  4  (13.3%) 1(3.3%)  0.35a
Hypotension  4  (13.3%) 2  (6.6%) 0.66a
Vomiting 1(3.3%)  4(13.3%)  0.35a
Shivering  1(3.3%)  3  (10%)  0.61a
Fentanyl  necessity  1(3.3%)  7  (23.3%)  0.052a
Nitroglycerine  necessity  2  (6.6%)  10  (33.3%)  0.02a
Total  rocuronium  necessity  (mg) 53.4  ±  11.4 49.9  ±  9.57 0.205
Group D, dexmedetomidine group; Group M, magnesium sulfate group.
Data show the number of cases or mean ± SD and the percentage rate.
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ap  values calculated using Student’s t -test and p < 0.05 value is sh
a p values calculated using 2 test (Fisher’s exact test) and p < 0
this  situation.  We  also  observed  that  bleeding  at  the  surgi-
cal site  was  decreased  and  surgeon  satisfaction  improved  in
the dexmedetomidine  study  group.  Shams  et  al.16 demon-
strated that  dexmedetomidine,  administered  as  a  1  g/kg
i.v. bolus  and  a  0.4--0.8  g/kg/h  i.v.  infusion,  was  safe  for
controlled hypotension  and  is  effective  in  providing  ideal
surgical ﬁeld  during  FESS.  In  a  study  by  Guven  et  al.2 com-
paring the  hypotensive  effects  of  dexmedetomidine  and
placebo agent,  it  was  concluded  that  dexmedetomidine  is
a safe  and  effective  agent  in  controlled  hypotension  and
can be  an  alternative  to  other  agents.  In  another  study
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Figure  1  Mean  arterial  pressure  for  the  groups. ap  <  0.05  signiﬁcan
dexmedetomidine,  signiﬁcant  difference  in  the  group  compared  to
difference  in  the  group  compared  to  baseline  values  (repeated  measn bold.
alue is shown in bold.
ssessing  the  effects  of  dexmedetomidine  administered  as
 1  g/kg  i.v.  bolus  and  a  0.7  g/kg/hour  i.v.  infusion,  it
as stated  that  dexmedetomidine  decreased  bleeding  at
he surgical  site,  improved  the  visibility  of  the  surgical  site
nd decreased  the  need  for  intraoperative  fentanyl.10 The
nalgesic effects  of  dexmedetomidine  can  be  due  to  the
ctivation of  2B-adrenoceptors  at  the  level  of  the  dorsal
orn of  the  spinal  cord  and  the  inhibition  of  substance  P
elease.17 In  our  study,  there  was  no  signiﬁcant  difference  in
erms of  fentanyl  need;  this  lack  of  necessity  was  attributed
o both  agents  having  analgesic  effects.
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ures  ANOVA  test  after  Bonferroni’s  test).
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Figure  2  Heart  rate  values  in  the  groups. ap  <  0.05  signiﬁcant  difference  between  the  groups  (Student’s  t  test), bp:  Group
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this study  was  approximately  half  of  the  dose  for  the  usualigure  3  Rating  of  bleeding  quantity.  p  values  calculated
sing 2 test  (Fisher’s  exact  test)  (*p  =  0.001).
The  use  of  different  doses  of  magnesium  to  perform
eliberate hypotension  has  been  studied.  In  a  study  compar-
ng magnesium  sulfate  with  placebo  in  patients  undergoing
ESS, it  was  stated  that  controlled  hypotension  was  achieved
y using  40  mg/kg  i.v.  bolus  and  15  mg/kg/hour  i.v.  infu-
ion of  magnesium  sulfate  and  that  the  use  of  this  agent
ecreased bleeding  and  duration  of  surgery.5 Ryu  et  al.7
ompared  magnesium  sulfate  with  remifentanil  in  patients
ndergoing middle  ear  surgery.  Magnesium  sulphate  was
dministered as  a  50  mg/kg  i.v.  bolus  and  15  mg/kg/hour
.v. infusion  in  the  same  study.  They  stated  that  controlled
ypotension could  be  achieved  with  both  agents,  but  that
agnesium sulfate  provided  more  effective  analgesia  in  the
ostoperative period.  Since  there  was  no  signiﬁcant  differ-
nce between  the  two  groups  in  terms  of  NRS  scores  in
t
s
ao  baseline  values, p:  group  magnesium  sulphate,  signiﬁcant
sures  ANOVA  test  after  Bonferroni’s  test).
his  study,  antinociceptive  effects  were  attributed  to  both
gents. The  antagonist  effect  of  magnesium  at  N-methyl-d-
spartate receptors  raised  interest  in  studies  searching  its
djuvant effect  in  perioperative  analgesia.18
Kalra  et  al.19 compared  magnesium  sulfate  with  cloni-
ine, which  is  another  2 receptor  antagonist,  in  patients
ndergoing laparoscopic  surgery;  it  was  stated  that  the  dura-
ion until  achieving  a  reply  to  verbal  stimulus  was  longer
n the  magnesium  sulfate  patient  group  compared  to  the
 g/kg  i.v.  and  1.5  g/kg  i.v.  clonidine  groups,  which  was
ttributed to  the  depressor  effects  of  magnesium  sulfate  on
he central  nervous  system.  There  was  no  signiﬁcant  dif-
erence in  terms  of  eye  opening  duration  between  the  two
roups. Furthermore  the  time  until  achieving  an  Aldrete
core ≥9  was  shorter  in  the  dexmedetomidine  patient  group,
uggesting that  dexmedetomidine  results  in  a sleeping  effect
n locus  coeruleus,  similar  to  that  of  normal  sleeping,  and
hus results  in  a  faster  awakening.  There  was  no  difference
n terms  of  adverse  effects  and  patient  number  requir-
ng fentanyl  administration.  Nevertheless,  the  need  for  an
dditional nitroglycerine  dose  in  order  to  obtain  adequate
ypotension was  higher  in  the  magnesium  sulfate  group,  a
ifference which  was  attributed  to  the  agent  doses  used  in
his study.  Additional  studies  conducted  with  different  doses
an contribute  to  this  subject.
In  this  study,  postoperative  magnesium  sulfate  and  cal-
ium levels  were  not  measured,  which  can  be  considered  as
ne limitation  of  the  study.  The  administration  of  a  large
ose of  magnesium  sulfate,  for  example  in  the  treatment
f preeclampsia,  may  cause  transient  hypocalcaemia  due  to
enal calcium  loss  or  the  inhibition  of  parathyroid  function.20
owever,  the  amount  of  magnesium  sulfate  administered  inreatment of  preeclampsia,  and  no  patient  exhibited  clinical
igns of  profound  neuromuscular  blockade.  In  another  study
ssessing the  hypotensive  anesthetic  effects  of  magnesium
11
1
1
1
1
1
1
1
1Controlled  hypotension  
sulfate  on  patients  undergoing  middle  ear  surgery,  no  sig-
niﬁcant difference  was  observed  between  the  preoperative
and postoperative  serum  magnesium  sulfate  levels.7
Conclusions
We  conclude  that  dexmedetomidine  used  at  the  doses  men-
tioned in  the  study  provided  controlled  hypotension  in  a
more effective  and  more  stable  manner  in  patients  undergo-
ing FESS,  and  also  increased  surgeon  satisfaction  and  quality
of surgical  site,  while  not  prolonging  the  recovery  period.
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